NCT01820130撤回不适用
Trial of Autonomic neuroModulation for trEatment of Chronic Heart Failure
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 试验地点
- 2
- 主要终点
- Efficacy Marker of patient symptom via 6 Minutes Hall Walk distance for patient with advanced HF
研究概览
简要总结
The purpose of this clinical investigation is to evaluate the safety and efficacy of Spinal Cord Stimulation (SCS) in advanced heart failure (HF) patients with Implantable Cardioverter Defibrillator (ICD) but not indicated for Cardiac Resynchronization Therapy (CRT).
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients has a Left Ventricular Ejection Fraction (LVEF) less than or equal to 35%
- •Patient is in New York Heart Association (NYHA) Class III
- •Patient has a QRS duration <120 ms (non-paced QRS, at the time of device Implant or protocol inclusion)
- •Patient has had an ICD implanted for >90 days
- •Patient is receiving stable and optimal medical therapy for HF (>90 days) as describe by "European Society of Cardiology 2012 recommendation for diagnosis and treatment of acute and chronic Heart Failure", except in case of contraindication or allergy
- •Patient is able to provide written Informed Consent prior to any investigational related procedure
排除标准
- •Patient currently has an implanted spinal cord stimulator or previously had an implanted spinal cord stimulator which is now explanted or has had previous spinal surgery that would interfere with implant of percutaneous SCS leads in the upper thoracic region
- •Patient has polyneuropathy
- •Patient requires short-wave diathermy, microwave diathermy or therapeutic ultrasound diathermy
- •Patient is in NYHA class IV
- •Patient has received a tissue / organ transplant or is expected to have a tissue / organ transplant within the next 180 days
- •Patient has a cardiac resynchronization therapy (CRT) device, or LV Assist device or is expected to receive CRT, or left ventricular assist device (LVAD) within the next 180 days
- •Patient has critical valvular heart disease that requires valve repair or replacement
- •Patient has had a myocardial infarction (MI) or cardiac revascularization procedure (percutaneous coronary intervention or coronary artery bypass graft) within 90 days of enrollment
- •Patient is on IV inotropic therapy
- •Patient has active myocarditis or early postpartum cardiomyopathy
- •Patient has taken any of the following drugs within 30 days of enrollment: systemic corticosteroids, cytostatic and immunosuppressive drug therapy (cyclophosphamide, methotrexate, cyclosporine, azathioprine, etc.), DNA depleting or cytotoxic drugs
- •Patient is pregnant, or of childbearing potential and is not using adequate contraceptive methods, or nursing
- •Patient with a bleeding tendency (INR >1.2 and platelet count <100 x109 per liter)
- •Patient has a local infection at the ICD implant location or systemic infection
- •Patient has renal insufficiency (creatinine >3.0 mg/dl)
- •Patient with risk of allergy to SCS device component materials
- •Patient having one of the following condition must be considered as non relevant for SCS implantation:
- •/ Patient with active stent
- •/ Patient having bare metal stent for less than 6 months
- •/ Patient presented with an acute coronary syndrome within the last 6 months
- •/ Patient with stent on the common
- •/ Patient with a history of stent thrombosis
- •/ Coronary Patient receiving double antiplatelet medication
- •Patient is participating in another clinical study with an active treatment arm
- •Patient is less than 18 years old
- •Patient's life's expectancy is less than 1 year as assessed by investigators
研究组 & 干预措施
Spinal Cord Stimulation system therapy
Experimental
St Jude Medical EON mini rechargeable system
干预措施: St Jude Medical EON mini rechargeable system (Device)
结局指标
主要结局
Efficacy Marker of patient symptom via 6 Minutes Hall Walk distance for patient with advanced HF
时间窗: baseline to 6 months
Evaluation of 6 Minutes Hall walk (6MHW) as marker of patient symptom between baseline and after 6 months of SCS therapy.
Efficacy Marker of Cardiac remodeling via Left Ventricular End Diastolic Volume (LVEDV) of Patient with advanced HF
时间窗: baseline and 6 Months
Evaluation of left ventricular end diastolic volume (LVEDV) as measured by cardiac echo between baseline and after 6 months of SCS therapy.
Efficacy Marker of patient symptom via NYHA class for patient with advanced HF
时间窗: Baseline and 6 months
Evaluation of NYHA class as marker of patient symptom between baseline and after 6 months of SCS therapy.
次要结局
- Additional efficacy markers of SCS therapy on cardiac function via echocardiography(baseline and 6 months)
- Safety composite marker of SCS therapy for patient with HF and ICD device(baseline and 6 months)
- Additional efficacy markers of SCS therapy on patient symptom via Maximal exercise test tolerance(baseline and 6 months)
- Additional efficacy markers of SCS therapy on patient symptom via Quality Of Life questionnaire(baseline to 6 months)
研究者
研究点 (2)
Loading locations...
相似试验
招募中
不适用
Neuromodulation With Spinal Stimulation MethodsSpinal Cord InjuriesSpinal Cord Injury at C5-C7 LevelParaplegia, SpinalParaplegia, IncompleteNCT06272279University of Manitoba24
进行中（未招募）
不适用
Brain Controlled Spinal Cord Stimulation In Participants With Spinal Cord Injury For Lower Limb RehabilitationSpinal Cord InjuriesParaplegiaNCT06243952Ecole Polytechnique Fédérale de Lausanne3
已完成
不适用
Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical StudySpinal Cord Injuries (Complete and Incomplete)Neurogenic BladderStrokeMultiple SclerosisNCT05301335SpineX Inc.126
终止
不适用
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) StudyFailed Back Surgery SyndromePost-Laminectomy SyndromeLow Back PainNCT01990287Abbott Medical Devices38
Unknown
4 期
Management of Chronic Pain in Military Patients With Injuries Sustained During Active DutyExtremity InjuryNCT01616342Sceptor Pain Foundation180